BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tsiapa I, Efthimiadou EK, Fragogeorgi E, Loudos G, Varvarigou AD, Bouziotis P, Kordas GC, Mihailidis D, Nikiforidis GC, Xanthopoulos S, Psimadas D, Paravatou-Petsotas M, Palamaris L, Hazle JD, Kagadis GC. (99m)Tc-labeled aminosilane-coated iron oxide nanoparticles for molecular imaging of ανβ3-mediated tumor expression and feasibility for hyperthermia treatment. J Colloid Interface Sci 2014;433:163-75. [PMID: 25128864 DOI: 10.1016/j.jcis.2014.07.032] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Lahooti A, Shanehsazzadeh S, Laurent S. Dual-Modality Imaging. Iron Oxide Nanoparticles for Biomedical Applications. Elsevier; 2018. pp. 165-96. [DOI: 10.1016/b978-0-08-101925-2.00006-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Ai F, Ferreira CA, Chen F, Cai W. Engineering of radiolabeled iron oxide nanoparticles for dual-modality imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2016;8:619-30. [PMID: 26692551 DOI: 10.1002/wnan.1386] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
3 Same S, Aghanejad A, Akbari Nakhjavani S, Barar J, Omidi Y. Radiolabeled theranostics: magnetic and gold nanoparticles. Bioimpacts 2016;6:169-81. [PMID: 27853680 DOI: 10.15171/bi.2016.23] [Cited by in Crossref: 57] [Cited by in F6Publishing: 43] [Article Influence: 9.5] [Reference Citation Analysis]
4 Burke BP, Cawthorne C, Archibald SJ. Multimodal nanoparticle imaging agents: design and applications. Philos Trans A Math Phys Eng Sci 2017;375:20170261. [PMID: 29038384 DOI: 10.1098/rsta.2017.0261] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 11.7] [Reference Citation Analysis]
5 Crețu BE, Dodi G, Shavandi A, Gardikiotis I, Șerban IL, Balan V. Imaging Constructs: The Rise of Iron Oxide Nanoparticles. Molecules 2021;26:3437. [PMID: 34198906 DOI: 10.3390/molecules26113437] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Migliari S, Sammartano A, Cidda C, Baldari G, Scarlattei M, Serreli G, Ghetti C, Pipitone S, Lippi G, Ruffini L. Novel approach for quality assessment and improving diagnostic accuracy in cell-based infection imaging using 99mTc-HMPAO labeled leukocytes. Acta Biomed 2018;89:355-64. [PMID: 30333459 DOI: 10.23750/abm.v89i3.7064] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Bharali DJ, Rajabi M, Mousa SA. Application of Nanotechnology to Target Tumor Angiogenesis in Cancer Therapeutics. Anti-Angiogenesis Strategies in Cancer Therapeutics. Elsevier; 2017. pp. 165-78. [DOI: 10.1016/b978-0-12-802576-5.00011-5] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
8 Pellico J, Gawne PJ, T M de Rosales R. Radiolabelling of nanomaterials for medical imaging and therapy. Chem Soc Rev 2021;50:3355-423. [PMID: 33491714 DOI: 10.1039/d0cs00384k] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
9 Farzin L, Sheibani S, Moassesi ME, Shamsipur M. An overview of nanoscale radionuclides and radiolabeled nanomaterials commonly used for nuclear molecular imaging and therapeutic functions. J Biomed Mater Res A 2019;107:251-85. [PMID: 30358098 DOI: 10.1002/jbm.a.36550] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
10 Yang Q, Gong M, Cai S, Zhang T, Douglas JT, Chikan V, Davies NM, Lee P, Choi IY, Ren S, Forrest ML. Combining hard and soft magnetism into a single core-shell nanoparticle to achieve both hyperthermia and image contrast. Ther Deliv 2015;6:1195-210. [PMID: 26606855 DOI: 10.4155/tde.15.68] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
11 Gavilán H, Avugadda SK, Fernández-Cabada T, Soni N, Cassani M, Mai BT, Chantrell R, Pellegrino T. Magnetic nanoparticles and clusters for magnetic hyperthermia: optimizing their heat performance and developing combinatorial therapies to tackle cancer. Chem Soc Rev 2021;50:11614-67. [PMID: 34661212 DOI: 10.1039/d1cs00427a] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Pijeira MSO, Viltres H, Kozempel J, Sakmár M, Vlk M, İlem-Özdemir D, Ekinci M, Srinivasan S, Rajabzadeh AR, Ricci-Junior E, Alencar LMR, Al Qahtani M, Santos-Oliveira R. Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology. EJNMMI Radiopharm Chem 2022;7:8. [PMID: 35467307 DOI: 10.1186/s41181-022-00161-4] [Reference Citation Analysis]
13 Del Sol-fernández S, Portilla-tundidor Y, Gutiérrez L, Odio OF, Reguera E, Barber DF, Morales MP. Flower-like Mn-Doped Magnetic Nanoparticles Functionalized with α v β 3 -Integrin-Ligand to Efficiently Induce Intracellular Heat after Alternating Magnetic Field Exposition, Triggering Glioma Cell Death. ACS Appl Mater Interfaces 2019;11:26648-63. [DOI: 10.1021/acsami.9b08318] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
14 Krokidis MG, Louka M, Efthimiadou EK, Ferreri C, Chatgilialoglu C. Fatty Acid Remodeling of Membrane Glycerophospholipids Induced by Bleomycin and Iron Oxide Nanoparticles in Human Embryonic Kidney Cells. Chem Res Toxicol 2020;33:2565-72. [PMID: 32865980 DOI: 10.1021/acs.chemrestox.0c00162] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Pourgholi F, Hajivalili M, Farhad JN, Kafil HS, Yousefi M. Nanoparticles: Novel vehicles in treatment of Glioblastoma. Biomed Pharmacother 2016;77:98-107. [PMID: 26796272 DOI: 10.1016/j.biopha.2015.12.014] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 8.6] [Reference Citation Analysis]
16 Tsiapa I, Loudos G, Fragogeorgi EA, Bouziotis P, Psimadas D, Xanthopoulos S, Paravatou-Petsotas M, Palamaris L, Varvarigou AD, Karnabatidis D, Kagadis GC. Evaluation of ανβ3-mediated tumor expression with a 99mTc-labeled ornithine-modified RGD derivative during glioblastoma growth in vivo. Cancer Biother Radiopharm 2014;29:444-50. [PMID: 25405951 DOI: 10.1089/cbr.2014.1672] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
17 Mokhodoeva O, Vlk M, Málková E, Kukleva E, Mičolová P, Štamberg K, Šlouf M, Dzhenloda R, Kozempel J. Study of 223Ra uptake mechanism by Fe3O4 nanoparticles: towards new prospective theranostic SPIONs. J Nanopart Res 2016;18. [DOI: 10.1007/s11051-016-3615-7] [Cited by in Crossref: 40] [Cited by in F6Publishing: 12] [Article Influence: 6.7] [Reference Citation Analysis]
18 Lahooti A, Sarkar S, Laurent S, Shanehsazzadeh S. Dual nano-sized contrast agents in PET/MRI: a systematic review. Contrast Media Mol Imaging 2016;11:428-47. [PMID: 28102031 DOI: 10.1002/cmmi.1719] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
19 Ghosh S, Das T, Suman SK, Sarma HD, Dash A. Preparation and Preliminary Evaluation of 68Ga-Acridine: An Attempt to Study the Potential of Radiolabeled DNA Intercalator as a PET Radiotracer for Tumor Imaging. Anticancer Agents Med Chem 2020;20:1538-47. [PMID: 32357824 DOI: 10.2174/1871520620666200502002609] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Demin AM, Pershina AG, Nevskaya KV, Efimova LV, Shchegoleva NN, Uimin MA, Kuznetsov DK, Shur VY, Krasnov VP, Ogorodova LM. pHLIP-modified magnetic nanoparticles for targeting acidic diseased tissue. RSC Adv 2016;6:60196-9. [DOI: 10.1039/c6ra13178f] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
21 Datta P, Ray S. Nanoparticulate formulations of radiopharmaceuticals: Strategy to improve targeting and biodistribution properties. J Labelled Comp Radiopharm 2020. [PMID: 32220029 DOI: 10.1002/jlcr.3839] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
22 Swidan MM, Khowessah OM, El-Motaleb MA, El-Bary AA, El-Kolaly MT, Sakr TM. Iron oxide nanoparticulate system as a cornerstone in the effective delivery of Tc-99 m radionuclide: a potential molecular imaging probe for tumor diagnosis. Daru 2019;27:49-58. [PMID: 30706223 DOI: 10.1007/s40199-019-00241-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
23 Krokidis MG, Louka M, Efthimiadou EK, Zervou SK, Papadopoulos K, Hiskia A, Ferreri C, Chatgilialoglu C. Membrane Lipidome Reorganization and Accumulation of Tissue DNA Lesions in Tumor-Bearing Mice: An Exploratory Study. Cancers (Basel) 2019;11:E480. [PMID: 30987375 DOI: 10.3390/cancers11040480] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
24 Andrade JT, Lima WG, Sousa JF, Saldanha AA, Nívea Pereira De Sá, Morais FB, Prates Silva MK, Ribeiro Viana GH, Johann S, Soares AC, Araújo LA, Antunes Fernandes SO, Cardoso VN, Siqueira Ferreira JM. Design, synthesis, and biodistribution studies of new analogues of marine alkaloids: Potent in vitro and in vivo fungicidal agents against Candida spp. Eur J Med Chem 2021;210:113048. [PMID: 33316690 DOI: 10.1016/j.ejmech.2020.113048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Karageorgou MA, Vranješ-Djurić S, Radović M, Lyberopoulou A, Antić B, Rouchota M, Gazouli M, Loudos G, Xanthopoulos S, Sideratou Z, Stamopoulos D, Bouziotis P, Tsoukalas C. Gallium-68 Labeled Iron Oxide Nanoparticles Coated with 2,3-Dicarboxypropane-1,1-diphosphonic Acid as a Potential PET/MR Imaging Agent: A Proof-of-Concept Study. Contrast Media Mol Imaging 2017;2017:6951240. [PMID: 29445321 DOI: 10.1155/2017/6951240] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
26 Smith BE, Roder PB, Zhou X, Pauzauskie PJ. Nanoscale materials for hyperthermal theranostics. Nanoscale 2015;7:7115-26. [PMID: 25816102 DOI: 10.1039/c4nr06164k] [Cited by in Crossref: 37] [Cited by in F6Publishing: 5] [Article Influence: 6.2] [Reference Citation Analysis]
27 Varani M, Galli F, Auletta S, Signore A. Radiolabelled nanoparticles for cancer diagnosis. Clin Transl Imaging 2018;6:271-92. [DOI: 10.1007/s40336-018-0283-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
28 Farzin L, Saber R, Sadjadi S, Mohagheghpour E, Sheini A. Nanomaterials-based hyperthermia: A literature review from concept to applications in chemistry and biomedicine. Journal of Thermal Biology 2022. [DOI: 10.1016/j.jtherbio.2022.103201] [Reference Citation Analysis]
29 Aghanejad A, Omidi Y. Radiolabeled Theranostics. Noble Metal-Metal Oxide Hybrid Nanoparticles. Elsevier; 2019. pp. 535-47. [DOI: 10.1016/b978-0-12-814134-2.00025-5] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
30 Lima-tenório MK, Gómez Pineda EA, Ahmad NM, Fessi H, Elaissari A. Magnetic nanoparticles: In vivo cancer diagnosis and therapy. International Journal of Pharmaceutics 2015;493:313-27. [DOI: 10.1016/j.ijpharm.2015.07.059] [Cited by in Crossref: 106] [Cited by in F6Publishing: 86] [Article Influence: 15.1] [Reference Citation Analysis]
31 Thomas G, Demoisson F, Chassagnon R, Popova E, Millot N. One-step continuous synthesis of functionalized magnetite nanoflowers. Nanotechnology 2016;27:135604. [DOI: 10.1088/0957-4484/27/13/135604] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
32 Rego GNA, Nucci MP, Mamani JB, Oliveira FA, Marti LC, Filgueiras IS, Ferreira JM, Real CC, Faria DP, Espinha PL, Fantacini DMC, Souza LEB, Covas DT, Buchpiguel CA, Gamarra LF. Therapeutic Efficiency of Multiple Applications of Magnetic Hyperthermia Technique in Glioblastoma Using Aminosilane Coated Iron Oxide Nanoparticles: In Vitro and In Vivo Study. Int J Mol Sci 2020;21:E958. [PMID: 32023985 DOI: 10.3390/ijms21030958] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
33 Bredlau AL, Dixit S, Chen C, Broome AM. Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma. Curr Neuropharmacol 2017;15:104-15. [PMID: 26903150 DOI: 10.2174/1570159x14666160223121002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
34 Chen C, Wu CQ, Chen TW, Tang MY, Zhang XM. Molecular Imaging with MRI: Potential Application in Pancreatic Cancer. Biomed Res Int 2015;2015:624074. [PMID: 26579537 DOI: 10.1155/2015/624074] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Wu T, Chiu H, Yu J, Cautela MP, Sarmento B, das Neves J, Catala C, Pazos-perez N, Guerrini L, Alvarez-puebla RA, Vranješ-đurić S, Ignjatović NL. Nanotechnologies for early diagnosis, in situ disease monitoring, and prevention. Nanotechnologies in Preventive and Regenerative Medicine. Elsevier; 2018. pp. 1-92. [DOI: 10.1016/b978-0-323-48063-5.00001-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Chen Z, Fu H, Wu H, Huang J, Yao L, Zhang X, Li Y. Syntheses and Preliminary Evaluation of Dual Target PET Probe [18F]-NOTA-Gly3- E (2PEG4-RGD-WH701) for PET Imaging of Breast Cancer. Anticancer Agents Med Chem 2020;20:1548-57. [PMID: 32329699 DOI: 10.2174/1871520620666200424101936] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Power EA, Rechberger JS, Gupta S, Schwartz JD, Daniels DJ, Khatua S. Drug delivery across the blood-brain barrier for the treatment of pediatric brain tumors - An update. Adv Drug Deliv Rev 2022;185:114303. [PMID: 35460714 DOI: 10.1016/j.addr.2022.114303] [Reference Citation Analysis]